Morgan Stanley’s Nutraceutical International Co NUTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-55,323
| Closed | -$2.3M | – | 6747 |
|
|
2017
Q2 | $2.3M | Buy |
55,323
+42,934
| +347% | +$1.53M | ﹤0.01% | 3678 |
|
|
2017
Q1 | $386K | Sell |
12,389
-14,977
| -55% | -$508K | ﹤0.01% | 4989 |
|
|
2016
Q4 | $956K | Buy |
27,366
+19,947
| +269% | +$632K | ﹤0.01% | 4496 |
|
|
2016
Q3 | $232K | Sell |
7,419
-24,921
| -77% | -$642K | ﹤0.01% | 4950 |
|
|
2016
Q2 | $749K | Buy |
32,340
+2,994
| +10% | +$71.3K | ﹤0.01% | 4185 |
|
|
2016
Q1 | $715K | Buy |
29,346
+13,493
| +85% | +$327K | ﹤0.01% | 4200 |
|
|
2015
Q4 | $409K | Sell |
15,853
-25,407
| -62% | -$624K | ﹤0.01% | 4680 |
|
|
2015
Q3 | $974K | Buy |
41,260
+26,067
| +172% | +$624K | ﹤0.01% | 4130 |
|
|
2015
Q2 | $376K | Buy |
15,193
+2,890
| +23% | +$60.9K | ﹤0.01% | 4906 |
|
|
2015
Q1 | $242K | Sell |
12,303
-24,778
| -67% | -$466K | ﹤0.01% | 5112 |
|
|
2014
Q4 | $799K | Buy |
37,081
+3,124
| +9% | +$67.9K | ﹤0.01% | 4327 |
|
|
2014
Q3 | $710K | Buy |
33,957
+14,453
| +74% | +$336K | ﹤0.01% | 4329 |
|
|
2014
Q2 | $465K | Buy |
19,504
+4,916
| +34% | +$121K | ﹤0.01% | 4633 |
|
|
2014
Q1 | $379K | Buy |
14,588
+2,125
| +17% | +$55.1K | ﹤0.01% | 4743 |
|
|
2013
Q4 | $334K | Buy |
+12,463
| New | +$309K | ﹤0.01% | 4748 |
|
Morgan Stanley's NUTR Position: Q3 2017 in Review
Morgan Stanley sold out of Nutraceutical International Co (NUTR) in Q3 2017, closing a stake of 55,323 shares — an estimated $2.3M sold.
Morgan Stanley first reported a position in NUTR in Q4 2013 and held it in 15 quarters. The position peaked at $2.3M in Q2 2017. 0 funds tracked by Wall St. Rank hold NUTR as of Q3 2017.
- Morgan Stanley reported no remaining Nutraceutical International Co position as of Q3 2017 after selling out during the quarter.
- Morgan Stanley sold 55,323 Nutraceutical International Co shares in Q3 2017, an estimated $2.3M.
- Morgan Stanley first reported a position in Nutraceutical International Co in Q4 2013 and held it in 15 quarters.
- Morgan Stanley's Nutraceutical International Co position peaked at $2.3M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Nutraceutical International Co as of Q3 2017.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.